About
Immuto Scientific develops a patented AI-enabled platform that uses ultrasensitive mass spectrometry and machine learning to characterize disease-specific surface protein conformations, primarily for identifying novel targets in cancer therapeutics.
Explore Immuto Scientific's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.